Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dazhu Hongjingtian injection in stable and unstable angina
ChiCTR2200065659Phase 4Not yet recruiting
- Sponsor
- Institute of Basic Research in Clinical Medicine
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Dazhuhongjingtian in stable angina and unstable angina (4 arms), sponsored by Institute of Basic Research in Clinical Medicine. Primary endpoints: Number of angina attacks before discharge and 30-day incidence of adverse cardiovascular and cerebrovascular events. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
Dazhuhongjingtian
03
Conditions
stable anginaunstable angina
Beyond the preview
Go deeper on ChiCTR2200065659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065659.